EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Feasibility of an Integrated Digital and Pharmacological Approach Targeting Blood Lipids in Atherosclerotic Cardiovascular Disease Management

Xu Yi, Qiu Weiyu, Li Yan, Lan Xianwu, Wu Shaorong

Cardiovascular Innovations and Applications · 2024 · 9 (1)

DOI: 10.15212/cvia.2024.0002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Innovations and Applications, 2024. Verfasst von Xu Yi und 4 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Strong evidence supports the importance of lipid-lowering and exercise therapies in the long-term therapy of atherosclerotic cardiovascular disease (ASCVD). Establishing efficient comprehensive intervention programs that combine pharmacological and exercise prescription is crucial to investigate with the aid of digital technologies.

Methods

A convenience sample of 25 ASCVD patients (57.8 ± 9.5 years, 76% males) was gathered. All participants were prescribed with 12-week home exercise program supervised by an app and bimonthly 75mg alirocumab subcutaneous injections. Follow up visits were scheduled at the end of 4th and 12th week.

Results

Nineteen participants completed the program with a retention rate of 76%. Sixteen (84.2%) participants received all six doses of alirocumab. The total management time of the 12-week program added up to 65.47 minutes per patient. Satisfaction score was 4.2 ± 0.6 and the User Version of the Mobile Application Rating Scale (uMARS) overall objective quality score on the app was 3.4 ± 0.7. At the 4-week and 12-week follow-ups, LDL-C levels reduced compared to baseline (−1.5 ± 0.8 mmol/L, P < 0.001, −1.6 ± 0.8 mmol/L, P < 0.001, respectively), along with TC (−1.8 ± 1.2 mmol/L, P < 0.001, −1.6 ± 1.3 mmol/L, P < 0.001, respectively), but not TG, HDL-C, GAD-7 and PHQ-9.

Conclusion

The integrated pharmaceutical and digital ERx intervention program was feasible and well accepted in ASCVD patients.

Zitieren

APA

Yi, X., Weiyu, Q., Yan, L., Xianwu, L., & Shaorong, W. (2024). Feasibility of an Integrated Digital and Pharmacological Approach Targeting Blood Lipids in Atherosclerotic Cardiovascular Disease Management. Cardiovascular Innovations and Applications, 9(1). https://doi.org/10.15212/cvia.2024.0002

Vancouver

Yi X, Weiyu Q, Yan L, Xianwu L, Shaorong W. Feasibility of an Integrated Digital and Pharmacological Approach Targeting Blood Lipids in Atherosclerotic Cardiovascular Disease Management. Cardiovascular Innovations and Applications. 2024;9(1). doi:10.15212/cvia.2024.0002

BibTeX
@article{Yi2024,
  author = {Yi, Xu and Weiyu, Qiu and Yan, Li and Xianwu, Lan and Shaorong, Wu},
  title = {Feasibility of an Integrated Digital and Pharmacological Approach Targeting Blood Lipids in Atherosclerotic Cardiovascular Disease Management},
  journal = {Cardiovascular Innovations and Applications},
  year = {2024},
  volume = {9},
  number = {1},
  doi = {10.15212/cvia.2024.0002}
}
Kostenlos starten →